There are 3 most feasible strategies that are co-expression, asynchronous. Conclusion: Flow cytometry can determine the aberrant immunophenotypes for observing MRD easely and precisely on acute leukemias. ABR: MRD: minimal residual disease, ALL: acute lymphononic leukemia, AML: acute myeloid leukemia, LAP: leukemia-associated phenotypes